Cyren was founded in 1991 and is headquartered in Tysons, US
Cyren Office Locations
Cyren has offices in Tysons, Sunnyvale, Austin, Greenfield and in 3 other locations
Tysons, US (HQ)
5200 7925 Jones Branch Dr
Reykjavík, IS
Thverholti 18
Berlin, DE
2 Hardenbergplatz
Herzliya, IL
1 Sapir St., 5th Floor, Beit Ampa P.O. Box 4014
Austin, US
130 10801 N Mopac Expy
Sunnyvale, US
110 1230 Midas Way
Cyren Data and Metrics
Cyren Financial Metrics
Cyren's revenue was reported to be $31 m in FY, 2016 which is a 12% increase from the previous period.
USD
Revenue (FY, 2016) | 31 m |
Revenue growth (FY, 2015 - FY, 2016), % | 12% |
Gross profit (FY, 2016) | 20.9 m |
Gross profit margin (FY, 2016), % | 68% |
Net income (FY, 2016) | (6.2 m) |
EBIT (FY, 2016) | (6.1 m) |
Market capitalization (26-Jun-2017) | 78.4 m |
Closing share price (26-Jun-2017) | 2.1 |
Cash (31-Dec-2016) | 10.6 m |
EV | 67.7 m |
Cyren's current market capitalization is $78.4 m.
- Source: SEC Filings
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Revenue | 31.9 m | 27.8 m | 31 m |
Revenue growth, % | (13%) | 12% | |
Cost of goods sold | 8.6 m | 8.9 m | 10 m |
Gross profit | 23.3 m | 18.9 m | 20.9 m |
Gross profit Margin, % | 73% | 68% | 68% |
Sales and marketing expense | 11.6 m | 8.5 m | 10.8 m |
R&D expense | 11.1 m | 8.8 m | 8.7 m |
General and administrative expense | 7.9 m | 6.1 m | 6.6 m |
Operating expense total | 30.6 m | 23.4 m | 26.1 m |
EBIT | (6.5 m) | (4.5 m) | (6.1 m) |
EBIT margin, % | (20%) | (16%) | (20%) |
Interest expense | 874 k | 243 k | 147 k |
Pre tax profit | (7.2 m) | (4.7 m) | (6.2 m) |
Income tax expense | (196 k) | 123 k | (2 k) |
Net Income | (7 m) | (4.8 m) | (6.2 m) |
- Source: SEC Filings
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
Cash | 16.4 m | 10.6 m |
Accounts Receivable | 3.8 m | 3.1 m |
Current Assets | 21.1 m | 14.6 m |
PP&E | 2.3 m | 2.1 m |
Goodwill | 19.9 m | 19.4 m |
Total Assets | 54.4 m | 47.5 m |
Accounts Payable | 603 k | 764 k |
Total Debt | 4.2 m | |
Current Liabilities | 13.7 m | 11.7 m |
Non-Current Liabilities | 3.4 m | 4.1 m |
Additional Paid-in Capital | 215.2 m | 216.1 m |
Retained Earnings | (172.9 m) | (179.2 m) |
Total Equity | 37.3 m | 31.7 m |
EPS | (0.1) | (0.2) |
Debt to Equity Ratio | 0.1 x | |
Debt to Assets Ratio | 0.1 x | |
Financial Leverage | 1.5 x | 1.5 x |
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Net Income | (7 m) | (4.8 m) | (6.2 m) |
Depreciation and Amortization | 3 m | 2.9 m | 4.1 m |
Accounts Receivable | 866 k | 716 k | 759 k |
Accounts Payable | (542 k) | (110 k) | 124 k |
Cash From Operating Activities | (3.7 m) | (1.8 m) | 2.4 m |
Purchases of PP&E | (771 k) | (1.2 m) | (985 k) |
Cash From Investing Activities | (762 k) | (3.1 m) | (4.1 m) |
Long-term Borrowings | (5.3 m) | (5.2 m) | (4.2 m) |
Cash From Financing Activities | 11.8 m | 10.4 m | (4.1 m) |
| Y, 2016 | |
|---|---|
P/E Ratio | (12.8) |
EV/EBIT | -11.2 x |
EV/CFO | 28 x |
Financial Leverage | 1.5 x |
